The Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mallikarjun Rao Basaboini & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mallikarjun Rao Basaboini along with three Persons Acting in Concert (Basaboini Malathi, Mrinalini Basaboini, Mriganayani Basaboini) acquired a total of 15,00,000 equity shares of Samsrita Labs Ltd on July 18, 2025 through a preferential allotment on a cash basis. Basaboini Malathi and Mallikarjun Rao Basaboini each received 5,00,000 shares (2.20% each), while Mrinalini Basaboini and Mriganayani Basaboini each received 2,50,000 shares (1.10% each), bringing their combined post-acquisition holding to 6.6% of the company's share capital. The disclosure explicitly states the acquirers do NOT belong to the promoter or promoter group. The preferential issue expanded the company's total equity share capital from 1,48,08,706 shares to 2,27,49,710 shares of Rs. 10 each, resulting in dilution for existing shareholders.
This is a fresh equity issuance, not a secondary market purchase, so existing shareholders are diluted by approximately 53% in their proportional ownership as the share base expanded significantly. The entry of non-promoter acquirers holding 6.6% signals fresh capital infusion into the company, though it also introduces new minority shareholders whose interests shareholders should monitor in future disclosures.